The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Kamchatnov P.R.

Kafedra nevrologii i neĭrokhirurgii Rossiĭskogo gosudarstvennogo meditsinskogo universiteta im. N.I. Pirogova, Moskva

Zaĭtsev K.A.

Poliklinika vosstanovitel'nogo lecheniia #7, Moskva

Chugunov A.V.

Kafedra nevrologii i neĭrokhirurgii Rossiĭskogo gosudarstvennogo meditsinskogo universiteta im. N.I. Pirogova, Moskva

Chronic disorders of cerebral blood circulation: possibilities of the use of cavinton

Authors:

Kamchatnov P.R., Zaĭtsev K.A., Chugunov A.V.

More about the authors

Read: 8095 times


To cite this article:

Kamchatnov PR, Zaĭtsev KA, Chugunov AV. Chronic disorders of cerebral blood circulation: possibilities of the use of cavinton. S.S. Korsakov Journal of Neurology and Psychiatry. 2010;110(4‑2):52‑56. (In Russ.)

References:

  1. Bogousslavsky J. On behalf of the European Stroke Initiative. Stroke prevention by the practitioner. Cerebrovasc Dis 1999; 9: Suppl 4:1-68.
  2. Gusev E.I., Kamchatnov P.R. Plastichnost' golovnogo mozga v norme i patologii. Zhurn nevrol i psikhiat 2004; 2: 73-80.
  3. Suslina Z.A. Kavinton v lechenii bol'nykh s ishemicheskimi narusheniyami mozgovogo krovoobrashcheniya. Rus med zhurn 2003; 10; 25: 1170-1174.
  4. Hindmarch I. Calcium antagonist activity of vinpocetine and vincamine in several models of cerebral ischemia. Drug Dev Res 1988; 14: 3/4: 297-304.
  5. Khorvat Sh. Kavinton v terapii khronicheskoi nedostatochnosti mozgovogo krovoobrashcheniya. Orvosi Hetilap 2001; 8: 383-389.
  6. Kiss B., Karpati E. Mechanism of action of vinpocetine. Acta Pharm Hung 1996; 66: 5: 213-224.
  7. Solti F., Iskum M., Czako E. Effect of ethyl apovincaminate on cerebral circulation. Studies in patients with obliterative cerebral arterial disease. Arzneim-Forschung 1986; 26: 1945-1947.
  8. Khadzhiev D. Neiroprotektivnaya terapiya pri latentnykh formakh nedostatochnosti mozgovogo krovoobrashcheniya kak pervichnaya profilaktika ishemicheskogo insul'ta. Kachestvennaya klin prakt 2003; 2; 1-5.
  9. Hayakawa M. Effect of vinpocetine on red blood cell deformabilitty in stroke patients. Arzneim-Forschung 1992; 42: 4: 425-427.
  10. Sapari L., Khorvat B., Aleksi T. i dr. Vliyanie kavintona na reologicheskie svoistva krovi u bol'nykh s khronicheskoi tserebrovaskulyarnoi nedostatochnost'yu. Zhurn nevrol i psikhiat 2006; 6: 42-49.
  11. Gusev E.I., Skvortsova V.I. Ishemiya golovnogo mozga. M: Meditsina 2001.
  12. Szakall S., Boros I., Balkay L. et al. Cerebral effects of a single dose of intravenous vinpocetine in chronic stroke patients: a PET study. J Neuroimaging 1998; 8: 4: 197-204.
  13. Shibota M., Kakihana M., Nagaoka A. The effect of vinpocetine on brain glucose uptake in mice. Nippon Yakurigaku Zasshi 1982; 80: 3: 221-224.
  14. Vas A., Gulyas B., Szabo Z. et al. Clinical and non-clinical investigations using positron emission tomography, near infrared spectroscopy and transcranial Doppler methods on the neuroprotective drug vinpocetine: a summary of evidences. J Neurol Sci 2002; 203/204: 259-262.
  15. Coleston D., Hindmarch I. Possible memory-enhancing properties of vinpocetine. Drug Dev Res 1988; 14: 191-193.
  16. Skoromets A.A., Tanashyan M.M., Chukanova E.I. i dr. Mnogotsentrovaya programma po otsenke effektivnosti i bezopasnosti novoi skhemy terapii bol'nykh s khronicheskoi tserebrovaskulyarnoi nedostatochnost'yu. Zhurn nevrol i psikhiat 2009; 5: 47-52.
  17. Gavrilova S.I., Kolykhalov I.V., Fedorova Ya.B. i dr. Vozmozhnosti preventivnoi terapii bolezni Al'tsgeimera: rezul'taty 3-letnego prospektivnogo otkrytogo sravnitel'nogo issledovaniya effektivnosti i bezopasnosti kursovoi terapii tserebrolizinom i kavintonom u pozhilykh patsientov s sindromom myagkogo kognitivnogo snizheniya. Zhurn nevrol i psikhiat 2009; 12: 85-93.
  18. Odinak M.M., Lobzin V.Yu. Primenenie kavintona v terapii kognitivnykh narushenii u bol'nykh s distsirkulyatornoi entsefalopatiei. Zhurn nevrol i psikhiat 2009; 10: 65-69.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.